Parallel drug distribution and substitution
- Published: November 30, 2020
- Last updated: November 30, 2020
A parallel-distributed drug is the exact same product and has the same name as the directly distributed drug. Therefore, the Swedish MPA makes no decision on substitution, but the list of substitutable drugs still shows parallel-distributed drugs.
Package appearance may vary somewhat because parallel-distributed packages receive an approved Swedish label and package leaflet for sale in Sweden. In other respects, product information is identical.
The prescriber may refuse substitution on medical grounds.
Did you benefit from the content of this page?
Contact us
Swedish Medical Products Agency (Läkemedelsverket)
Opening hours: weekdays 8:00 am to 4:30 pm CET
Telephone: +46 (0)18-17 46 00
Email: registrator@lakemedelsverket.se